“…The glucoamylase inhibitors which have been investigated were mostly sugar analogues, such as hexoses, hexosamines, phenyl-and methyl glucosides (12), gluconolactone (13), maltitol (4,9), 1-deoxy nojirimycin (5-amino-l,5-dideoxy r> glucopyranose) (14), and oligosaccharides containing glucose and hexosamine (15). On the other hand, it was reported by Yamasaki et al that tris-(hydroxymethyl)aminomethane (Tris), which is widely used as a buffer, reduced glucoamylase activity (16)(17)(18)(19), and the mode of inhibition was found to be competitive (18,19). Since Tris, which has no sugar moieties, inhibits glucoamylase, in this work, we studied the interaction between glucoamylases and Tris and its analogues using the two glucoamylases described above as model enzymes.…”